Details for New Drug Application (NDA): 085311
✉ Email this page to a colleague
NDA 085311 describes LONOX, which is a drug marketed by Fosun Pharma and is included in one NDA. Additional details are available on the LONOX profile page.
The generic ingredient in LONOX is atropine sulfate; diphenoxylate hydrochloride. There are twenty-three drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the atropine sulfate; diphenoxylate hydrochloride profile page.
The generic ingredient in LONOX is atropine sulfate; diphenoxylate hydrochloride. There are twenty-three drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the atropine sulfate; diphenoxylate hydrochloride profile page.
Summary for 085311
| Tradename: | LONOX |
| Applicant: | Fosun Pharma |
| Ingredient: | atropine sulfate; diphenoxylate hydrochloride |
| Patents: | 0 |
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.025MG;2.5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
